Hacker, Marcus

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Kornauth, C., Pemovska, T., Vladimer, G. I., Bayer, G., Bergmann, M., Eder, S., Eichner, R., Erl, M., Esterbauer, H., Exner, R., et al. (2022) · Cancer Discovery

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research

Cited by 206

In Vivo Imaging of Macrophage Activity in the Coronary Arteries Using 68Ga-DOTATATE PET/CT: Correlation with Coronary Calcium Burden and Risk Factors

Rominger, A., Saam, T., Vogl, E., Übleis, C., la Fougère, C., Förster, S., Haug, A., Cumming, P., Reiser, M. F., Nikolaou, K., et al. (2010) · Journal of Nuclear Medicine

Cardiac Imaging and DiagnosticsMedical Imaging Techniques and Applications

Cited by 159

The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography

Vanicek, T., Spies, M., Rami-Mark, C., Savli, M., Höflich, A., Kranz, G. S., Hahn, A., Kutzelnigg, A., Traub-Weidinger, T., Mitterhauser, M., et al. (2014) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 61

Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder

la Fougère, C., Krause, J., Krause, K.-H., Josef Gildehaus, F., Hacker, M., Koch, W., Hahn, K., Tatsch, K., & Dresel, S. (2006) · Nuclear Medicine Communications

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 57

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET

Sigurdardottir, H. L., Kranz, G. S., Rami‐Mark, C., James, G. M., Vanicek, T., Gryglewski, G., Kautzky, A., Hienert, M., Traub‐Weidinger, T., Mitterhauser, M., et al. (2016) · Human Brain Mapping

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 51

Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET: Serotonin Transporter in ADHD Revealed by PET

Vanicek, T., Kutzelnigg, A., Philippe, C., Sigurdardottir, H. L., James, G. M., Hahn, A., Kranz, G. S., Höflich, A., Kautzky, A., Traub-Weidinger, T., et al. (2017) · Human Brain Mapping

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 44

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography

Spies, M., James, G. M., Berroterán-Infante, N., Ibeschitz, H., Kranz, G. S., Unterholzner, J., Godbersen, M., Gryglewski, G., Hienert, M., Jungwirth, J., et al. (2018) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 34

Standard MRI-based attenuation correction for PET/MRI phantoms: a novel concept using MRI-visible polymer

Rausch, I., Valladares, A., Sundar, L. K. S., Beyer, T., Hacker, M., Meyerspeer, M., & Unger, E. (2021) · EJNMMI Physics

Medical Imaging Techniques and ApplicationsAdvanced MRI Techniques and Applications

Cited by 11